US20020010412A1 - Multiple mechanical microporation of skin or mucosa - Google Patents

Multiple mechanical microporation of skin or mucosa Download PDF

Info

Publication number
US20020010412A1
US20020010412A1 US09852935 US85293501A US2002010412A1 US 20020010412 A1 US20020010412 A1 US 20020010412A1 US 09852935 US09852935 US 09852935 US 85293501 A US85293501 A US 85293501A US 2002010412 A1 US2002010412 A1 US 2002010412A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
device
base
method
puncturing
mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09852935
Inventor
Jonathan Eppstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spectrx Inc
Original Assignee
Spectrx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0092Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023Drug applicators using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053Methods for producing microneedles

Abstract

A device and methods of use for delivering a drug to the body, or monitoring an analyte found in the body, are described. The device includes a base, a plurality of puncturing members extending from the base, a plurality of holes extending through the base for the passage of the drug or the analyte, and a network of channels for distributing the drug or collecting the analyte. Methods of trans-dermal or trans-mucous delivery of a drug or monitoring of an analyte are also described.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application No. 60/021,212, filed Jul. 3, 1996.[0001]
  • BACKGROUND OF THE INVENTION
  • This invention relates to a device and method for puncturing a selected layer or layers of the skin or mucosa. More particularly, the invention relates a device and method for puncturing the stratum corneum or mucosa to diminish the barrier function thereof and permit a drug to be delivered to the body or an analyte in the body to be withdrawn for monitoring. This puncturing of the stratum corneum or mucosa is minimally is invasive, and can be combined with various other methods, such as use of chemical enhancers, pressure gradients, sonic gradients, temperature gradients, and the like for selectively enhancing the inward flux of a drug to the body or the outward flux of an analyte from the body. [0002]
  • The stratum corneum is chiefly responsible for the well-known barrier properties of skin. Thus, it is this layer of the skin that presents the greatest barrier to transdermal flux of drugs or other molecules into the body and of analytes out of the body. Mucosal tissue also presents a barrier to flux of molecules into and out of the body. The stratum corneum, the outer horny layer of the skin, is a complex structure of compact keratinized cell remnants separated by lipid domains. Compared to the oral or gastric mucosa, the stratum corneum is much less permeable to molecules either external or internal to the body. The stratum corneum is formed from keratinocytes, which comprise the majority of the epidermal cells, that lose their nuclei and become corneocytes. These dead cells comprise the stratum corneum, which has a thickness of about 10-30 μm and, as noted above, is a very resistant waterproof membrane that protects the body from invasion by exterior substances and the outward migration of fluids and dissolved molecules. The stratum corneum is continuously renewed by shedding of corneum cells during desquamination and the formation of new corneum cells by the keratinization process. [0003]
  • Various methods of enhancing the permeability of the stratum corneum and mucosa have been described. For example, U.S. Pat. No. 5,458,140 and U.S. Pat. No. 5,445,611 disclose using ultrasonic energy that is modulated in intensity, phase, or frequency or a combination thereof. U.S. Pat. No. 4,775,361 discloses a method of administering a drug by ablating the stratum corneum using pulsed laser light without significantly damaging the underlying epidermis. Numerous patents teach the use of chemical enhancers for improving transdermal flux of a drug through the skin. E.g., U.S. Pat. No. 4,863,970. It would be advantageous to develop additional methods of permeating the stratum corneum or mucosa to enhance the transport of drugs into the body or analytes out of the body, particularly without the need for expensive or complicated equipment. [0004]
  • In view of the foregoing, it will be appreciated that providing a device and method of use thereof for introducing multiple micropores or perforations in the stratum corneum or mucosa for enhancing transport of molecules therethrough would be a significant advancement in the art. [0005]
  • BRIEF SUMMARY OF THE INVENTION
  • It is an object of the present invention to provide a simple, inexpensive device for puncturing the stratum corneum or mucosa without significantly damaging the underlying tissues to facilitate transport of molecules therethrough. [0006]
  • It is also an object of the invention to provide a method of enhancing the passage of molecules through the stratum corneum or mucosa. [0007]
  • It is another object of the invention to provide a method for transdermally or transmucosally delivering a drug. [0008]
  • It is still another object of the invention to provide a method for transdermally or transmucosally monitoring an analyte. [0009]
  • These and other objects can be achieved by providing a device for reducing the barrier properties of skin or mucosa to the delivery of a substance into the body or the withdrawal of an analyte from the body comprising: [0010]
  • (a) a base having a lower side and an upper side; [0011]
  • (b) a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues; [0012]
  • (c) a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and [0013]
  • (d) a network of channels configured in the upper side of the base to interconnect the holes. [0014]
  • Preferably, the device is fabricated by microlithography and is composed of a material selected from the group consisting of silicon, metal, and plastic. It is also preferred that the puncturing member be in the shape of a pyramid or wedge. The pyramid or wedge preferably have sharp edges having corner radii of less than 1 μm. The puncturing member is preferably configured for puncturing the skin or mucosa to a depth of about 30-50 μm, and a dimension at a base thereof is preferably about 10-50 μm. The puncturing members preferably occupy up to about 50% of the surface area of the lower surface of the base. [0015]
  • The device preferably further comprises a mechanism for producing vibrations, the vibrations for facilitating efficient and non-traumatic penetration of the puncturing members into the skin or mucosa. A preferred vibration-producing mechanism comprises a piezo-electric transducer. It is preferred that the mechanism for producing vibrations produces vibrations in the range of about 2000 Hz to about 100 MHz. [0016]
  • In another illustrative embodiment of the device, an external reservoir for holding a liquid drug composition to be delivered to the body is provided. Still further, a mechanism for limiting the rate of drug delivery is preferably included in the device, the mechanism positioned between the external reservoir and the puncturing members. Such rate-limiting mechanisms can include selective permeability membranes and valve mechanisms. In another preferred embodiment, the device is disposable. [0017]
  • A method for reducing the barrier function of skin or mucosa to the delivery of substances into a body or withdrawal of analytes out of the body, comprises: [0018]
  • (a) providing a device comprising: [0019]
  • a base having a lower side and an upper side; [0020]
  • a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues; [0021]
  • a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and [0022]
  • a network of channels configured in the upper side of the base to interconnect the holes; [0023]
  • (b) contacting the device with the skin or mucosa such that the plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof. [0024]
  • A method of transdermal or transmucosal monitoring of a selected analyte in a body comprises: [0025]
  • (a) providing a device comprising: [0026]
  • a base having a lower side and an upper side; [0027]
  • a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing said skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues; [0028]
  • a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and [0029]
  • a network of channels configured in the upper side of the base to interconnect the holes, the network of channels including a reservoir; [0030]
  • (b) contacting the device with the skin or mucosa such that the plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof resulting in seepage of interstitial fluid to the surface of the skin or mucosa such that interstitial fluid moves by capillary action through the holes, through the channels, to the reservoir; [0031]
  • (c) collecting the interstitial fluid from the reservoir; and [0032]
  • (d) analyzing the interstitial fluid with respect to the selected analyte. [0033]
  • In a preferred embodiment, the method further comprises applying suction to increase the rate of collection of interstitial fluid. Ultrasonic vibrations can also be applied to the skin or mucosa to increase the rate of collection of the selected analyte. The ultrasonic vibrations can be modulated in frequency, intensity, phase, or a combination thereof, as disclosed in U.S. Pat. No. 5,458,140, hereby incorporated by reference. The ultrasonic vibrations are preferably in the range of about 2000 Hz to about 100 MHz. The ultrasonic vibrations can also enhance the movement of interstitial fluid by capillary action. In a preferred embodiment of the invention, the selected analyte is glucose. It is also preferred to apply an anticoagulant to inhibit obstruction of the holes or channels. [0034]
  • A method of transdermally or transmucosally delivering a drug in liquid form to a body comprises: [0035]
  • (a) providing a device comprising: [0036]
  • a base having a lower side and an upper side; [0037]
  • a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues; [0038]
  • a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and [0039]
  • a network of channels configured in the upper side of the base to interconnect the holes, the network of channels including a reservoir; [0040]
  • (b) contacting the device with the skin or mucosa such that the plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof; [0041]
  • (c) supplying the drug to the reservoir such that said drug moves from the reservoir, through the channels and holes to the site of the punctures of the skin or mucosa and thus into the body. [0042]
  • In a preferred embodiment, pressure is applied to increase the rate of delivery of the drug to the body. Applying ultrasonic vibrations to the skin or mucosa also increases the rate of delivery of the drug to the body. The ultrasonic vibrations can be modulated in frequency, intensity, phase, or a combination thereof, as disclosed in U.S. Pat. No. 5,445,611, hereby incorporated by reference. The ultrasonic vibrations are preferably in the range of about 2000 Hz to about 100 MHz. The drug in liquid form can further comprise an anti-irritant, antiseptic, or analgesic to reduce trauma to the body due to the application of the device.[0043]
  • BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
  • FIG. 1 shows a perspective view of an illustrative embodiment of the present invention. [0044]
  • FIG. 2 shows a cross section of a portion of another illustrative embodiment according to the present invention. [0045]
  • FIG. 3 shows a perspective view of a portion of the embodiment of FIG. 2. [0046]
  • FIG. 4 shows a top view of a portion of the embodiment of FIG. 2. [0047]
  • FIG. 5 shows a schematic diagram of a device for making multiple microporations in skin or mucosa and collecting interstitial fluid. [0048]
  • FIG. 6 shows a schematic sectional diagram of a device for making multiple microporations in skin or mucosa and delivering a drug.[0049]
  • DETAILED DESCRIPTION
  • Before the present device and method for enhancing permeability of skin or mucosa for drug delivery or analyte monitoring are disclosed and described, it is to be understood that this invention is not limited to the particular configurations, process steps, and materials disclosed herein as such configurations, process steps, and materials may vary somewhat. It is also to be understood that the terminology employed herein is used for the purpose of describing particular embodiments only and is not intended to be limiting since the scope of the present invention will be limited only by the appended claims and equivalents thereof. [0050]
  • It must be noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to a device containing “a puncturing member” includes a device containing two or more of such members, reference to “a channel” includes reference to one or more of such channels, and reference to “an ultrasound transducer” includes reference to two or more ultrasound transducers. [0051]
  • It has been observed that forming a hole or micropore, 30 μm across, in the stratum corneum yields a quick source of about 0.2 microliters of interstitial fluid seeping through the hole from the underlying tissue without any additional pumping. Merely increasing the number of holes introduced through the stratum corneum would increases the amount of passively available fluid in a linear fashion. That is, creating 100 holes should produce about 20 microliters of interstitial fluid. From a practical perspective, using known approaches to create 100 holes in a controlled pattern would be challenging and time-consuming. However, using the mechanical puncturing capabilities of a mechanical microporation or “bed-of-nails” device would allow an almost unlimited number of micropores to be quickly created in any selected pattern. Similarly, using conventional lancet and needle technologies would make the needed depth control of the puncture very tricky and, if the device were to create hundreds of these holes, the mechanical challenge of building the device using conventional metal needle technologies would be formidable. However, by fabricating puncturing elements en masse such that they protrude from a substantially planar surface, with sufficient spacing between each to allow the stratum corneum to come in contact with this intervening planar surface, the absolute length of the puncturing elements themselves would act as an accurate limit for the depth of the micropore. Also, using a microlithography approach to fabricate these structures will allow an entire surface comprised of puncturing elements and the interconnecting fluid management system to be built very cost effectively. [0052]
  • One illustrative method would be to utilize the existing base of manufacturing capabilities developed in the semiconductor and micro-mechanical industries to dry-etch an entire 4 inch silicon wafer with a network of these devices. This master could then be used as the basis for an electroplated mold from which thousands of copies could be produced. For a typical useable surface area/per device application of 4 mm×4 mm, one 4-inch wafer would yield more than 500 of the devices. [0053]
  • A device according to the present invention is made, for example, by first preparing a master by a dry etch process on a silicon wafer, as is well known in the art. Photolithographical processes for etching micrometer-scale structures into silicon waters and the like are described in A. T. Wooley & R. A. Mathies, Ultra-high-speed DNA fragment separations using microfabricated capillary array electrophoresis chips, 91 Biophysics 11348-52 (1994); C. S. Effenhauser et al., High-speed separation of antisense oligonucleotides on a micromachined capillary electrophoresis device, 66 Anal. Chem. 2949 (1994); C. Effenhauser et al., 65 Anal. Chem. 2637 (1993); Z. H. Fan & D. J. Harrison, Micromachining of capillary electrophoresis injectors and separators on glass chips and evaluation of flow at capillary intersections, 66 Anal. Chem. 177-84 (1994); W. H. Ko et al., in Sensors: A Comprehensive Survey, T. Grandke, W. H. Ko, eds., VCH Press: Weinheim, Germany, Vol. 1, pp. 107-68 (1989); K. E. Petersen, 70 Proc. IEEE 420-57 (1982), which are hereby incorporated by reference. The master silicon wafer is then used to make an electroplated mold, and then the mold is used to make copies of the device, all by processes well known in the art. [0054]
  • Also, by coupling the entire device to an ultrasonic transducer, several known advantages can be realized simultaneously. For example, ultrasound has been shown to enhance the smooth cutting ability of scalpels and other surgical devices and can be expected to facilitate the easy, painless penetration of the puncturing elements into the stratum corneum with very little pressure. The edges of the pyramidally shaped puncturing elements shown in FIG. 1 can easily be fabricated such that the corner radius is less than 10 nanometers, a sharpness similar to a surgical scalpel. Second, ultrasound has also been shown to greatly enhance capillary action, thus the amount of fluid that could be collected in a device containing a capillary collection system could be expected to be significantly greater than that provided by mere passive means. Third, by using the entire body of the puncturing elements to provide a conduit for the ultrasonic energy, a simple method is presented wherein the sonic energy is placed within the body where it can provide a positive pressure, and streaming action on the interstitial fluid from within the body outward towards a collection system of capillary channels coupling all fluid harvested into a central reservoir. [0055]
  • FIG. 1 shows a perspective view of an illustrative device according to the present invention. The device [0056] 10 comprises a base 14 with a plurality of puncturing members 18 extending therefrom. In a preferred embodiment, the base is substantially planar. Each puncturing member comprises a sharp point 22 or edge for puncturing the stratum corneum or mucosa. Since the stratum corneum can be up to about 30 μm thick, it is preferred that the puncturing element have a height of about 40-50 μm to ensure that the stratum corneum will be fully breached without significantly damaging the underlying tissue. A pyramid or wedge shape is a preferred shape for the puncturing member because of the ease with which such a shape can be formed by microfabrication techniques such as microlithography. In an illustrative puncturing element having a pyramid shape, the base of the pyramid would preferably have a square base about 30-40 μm on a side.
  • It is also preferred that the base have a plurality of holes [0057] 26 extending therethrough from the lower side 30, on which the puncturing element are disposed, to the upper side 34. Preferably, each puncturing element is adjacent to and paired with at least one hole for collecting the interstitial fluid that seeps out of the puncture in the stratum corneum. These holes should be dimensioned to permit the interstitial fluid to move by capillary action from the lower side of the device to the upper side, where the interstitial fluid can be collected. It is also preferred to interconnect the holes with capillary channels 38 that are formed in the upper side of the device. Preferably, such channels intersect at a reservoir 42. The interstitial fluid moves by capillarity from the micropore into the hole, through the channels, and to the reservoir, where the interstitial fluid is collected, such as with a micropipet. Additional fluid can be collected by applying suction to the microporated area of skin or mucosa.
  • FIGS. [0058] 2-4 show another illustrative embodiment of the invention. FIG. 2 shows a cross section of a portion of the device 50 comprising a base 54 with a puncturing member 58 extending therefrom. The puncturing member is pyramid-shaped, as in FIG. 1. The upper side 62 of the base is configured with a V-shaped channel 66 positioned such that the channel is directly over the puncturing member and cuts into the volume circumscribed by the puncturing member. FIG. 3 shows a perspective view of the device having the V-shaped channels 66 and interconnecting shallower V-grooves 70. The channels 66 cut through the lower side 74 of the base, and thus form openings through which the interstitial fluid can be taken up by capillary action. FIG. 4 shows how the V-grooves 70 interconnect the V-channels for collecting the interstitial fluid. All of the puncturing members, channels, and grooves shown in FIGS. 2,3, and 4 are designed to be wedge-shaped, compatible with being produced in the crystalline structure of a silicon substrate with a lithographic ‘dry-etch’ type of process.
  • FIG. 5 shows an illustrative device [0059] 80 for collecting interstitial fluid according to the present invention. The device 80 comprises a base 84 having a plurality of puncturing members 88 extending therefrom. V-shaped channels and grooves are configured into the upper side 92 of the base for collecting the interstitial fluid. A cover plate 96 fits over the base to cover the network of channels and grooves and to inhibit evaporation of the interstitial fluid. The network of channels and grooves leads the interstitial fluid to a central area, where there is disposed a capillary tube 100 for receiving the interstitial fluid. Atop the cover plate is disposed an ultrasonic transducer 104 and a backing 108 for the tranducer.
  • The device is pressed against a selected area of skin or mucosa, and the ultrasonic transducer is activated to aid in both the puncturing of the tissue and in enhancing the seepage of the interstitial fluid. The interstitial fluid is collected by the network of openings in the base, and is conducted by the network of channels and grooves to the capillary, which takes up the fluid by capillary action. The fluid is then analyzed according to methods known in the art. An illustrative analyte is glucose, which can be quantified with various test strips that are available commercially. [0060]
  • FIG. 6 shows an illustrative drug delivery device [0061] 120 comprising a base 124 having a plurality of puncturing members 128 extending therefrom. A network of grooves and channels (see FIGS. 2-4) is embedded in the base for distributing a drug composition 132 from a reservoir 136. The reservoir is bounded by a housing 138, the base, and a backing plate 144 including an O-ring 148. The drug composition flows through the channels, grooves, and openings in the base to the surface of the skin or mucosa for entry into the body through the punctures or perforations. An ultrasound transducer 140 lies over the drug composition for aiding in delivery thereof. Above the transducer is the backing plate 144 including the O-ring for sealing the drug in the reservoir. A spring 152 can advantageously bias the backing plate against the transducer, which causes the transducer to be kept in fluid contact with the drug.
  • The ultrasonic system is utilized not only to enhance the slicing action of the edges of the puncturing elements as the penetrate into the stratum corneum or mucosa, but is then utilized to enhance the fluid flux of the therapeutic containing solution through the micro-pores and into the underlying tissues. In this case, large quantities of large molecular weight drugs could be delivered transdermally with a programmable control of the flux rate via variable activation of the ultrasonic pumping system. In addition, the sonic energy can be utilized to create controlled resonant vibrations in specifically shaped micro-structures such that a micro-pump is created to facilitate driving the collected fluid from one point to another within the entire structure. Moreover, chemical enhancers, air pressure, and other methods known in the art can be used to enhance the passage of the drug through the micropores in the skin or mucosa into the body. [0062]

Claims (48)

    I claim:
  1. 1. A device for reducing the barrier properties of skin or mucosa to the delivery of a substance into the body or the withdrawal of an analyte from the body comprising:
    (a) a base having a lower side and an upper side;
    (b) a plurality of puncturing members extending from the lower side of the base, said puncturing members configured for puncturing said skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
    (c) a plurality of holes extending from the lower side of the base to the upper side of the base, said holes configured for permitting a liquid to move therethrough by capillary action; and
    (d) a network of channels configured in the upper side of said base to interconnect said holes.
  2. 2. The device of claim 1 wherein said device is fabricated by microlithography.
  3. 3. The device of claim 1 wherein said device is fabricated of a material selected from the group consisting of silicon, metal, and plastic.
  4. 4. The device of claim 1 wherein said puncturing member is in the shape of a pyramid or wedge.
  5. 5. The device of claim 4 wherein said pyramid or wedge comprises sharp edges having corner radii of less than 1 μm.
  6. 6. The device of claim 1 wherein said puncturing member is configured for puncturing said skin or mucosa to a depth of about 30-50 μm.
  7. 7. The device of claim 1 wherein said plurality of puncturing members occupy up to about 50% of the surface area of the lower surface of the base.
  8. 8. The device of claim 1 wherein said puncturing member has a dimension at a base thereof of about 10-50 μm.
  9. 9. The device of claim 1 wherein said each of said holes is positioned adjacent to a puncturing member.
  10. 10. The device of claim 1 wherein said network of channels further comprises a reservoir for holding liquid.
  11. 11. The device of claim 1 wherein said base is substantially planar.
  12. 12. The device of claim 1 further comprising a mechanism for producing vibrations, said vibrations for facilitating efficient and non-traumatic penetration of the puncturing members into the skin or mucosa.
  13. 13. The device of claim 12 wherein said mechanism for producing vibrations comprises a piezo-electric transducer.
  14. 14. The device of claim 12 wherein said mechanism for producing vibrations produces vibrations in the range of about 2000 Hz to about 100 MHz.
  15. 15. The device of claim 1 further comprising an external reservoir for holding a liquid drug composition to be delivered to the body.
  16. 16. The device of claim 15 further comprising a mechanism for limiting the rate of drug delivery, said mechanism positioned between the external reservoir and the puncturing members.
  17. 17. The device of claim 1 wherein said device is disposable.
  18. 18. A method for reducing the barrier function of skin or mucosa to the delivery of substances into a body or withdrawal of analytes out of the body, comprising:
    (a) providing a device comprising:
    a base having a lower side and an upper side;
    a plurality of puncturing members extending from the lower side of the base, said puncturing members configured for puncturing said skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
    a plurality of holes extending from the lower side of the base to the upper side of the base, said holes configured for permitting a liquid to move therethrough by capillary action; and
    a network of channels configured in the upper side of said base to interconnect said holes;
    (b) contacting said device with the skin or mucosa such that said plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof.
  19. 19. The method of claim 18 wherein said device is fabricated by microlithography.
  20. 20. The method of claim 18 wherein said device is fabricated of a material selected from the group consisting of silicon, metal, and plastic.
  21. 21. The method of claim 18 wherein said puncturing member is in the shape of a pyramid or wedge.
  22. 22. The method of claim 21 wherein said pyramid or wedge comprises sharp edges having corner radii of less than 1 μm.
  23. 23. The method of claim 18 wherein said puncturing member is configured for puncturing said skin or mucosa to a depth of about 30-50 μm.
  24. 24. The method of claim 18 wherein said plurality of puncturing members occupy up to about 50% of the surface area of the lower surface of the base.
  25. 25. The method of claim 18 wherein said puncturing member has a dimension at a base thereof of about 10-50 μm.
  26. 26. The method of claim 18 wherein said each of said holes is positioned adjacent to a puncturing member.
  27. 27. The method of claim 18 wherein said network of channels further comprises a reservoir for holding liquid.
  28. 28. The method of claim 18 wherein said base is substantially planar.
  29. 29. The method of claim 18 further comprising a mechanism for producing vibrations, said vibrations for facilitating efficient and non-traumatic penetration of the puncturing members into the skin or mucosa.
  30. 30. The method of claim 29 wherein said mechanism for producing vibrations comprises a piezo-electric transducer.
  31. 31. The method of claim 29 wherein said mechanism for producing vibrations produces vibrations in the range of about 2000 Hz to about 100 MHz.
  32. 32. The method of claim 18 further comprising an external reservoir for holding a liquid drug composition to be delivered to the body.
  33. 33. The method of claim 32 further comprising a mechanism for limiting the rate of drug delivery, said mechanism positioned between the external reservoir and the puncturing members.
  34. 34. The method of claim 18 wherein said device is disposable.
  35. 35. A method of transdermal or transmucosal monitoring of a selected analyte in a body comprising:
    (a) providing a device comprising:
    a base having a lower side and an upper side;
    a plurality of puncturing members extending from the lower side of the base, said puncturing members configured for puncturing said skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
    a plurality of holes extending from the lower side of the base to the upper side of the base, said holes configured for permitting a liquid to move therethrough by capillary action; and
    a network of channels configured in the upper side of said base to interconnect said holes, said network of channels including a reservoir;
    (b) contacting said device with the skin or mucosa such that said plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof resulting in seepage of interstitial fluid to the surface of said skin or mucosa such that interstitial fluid moves by capillary action through the holes, through the channels, to the reservoir;
    (c) collecting the interstitial fluid from the reservoir; and
    (d) analyzing the interstitial fluid with respect to the selected analyte.
  36. 36. The method of claim 35 further comprising applying suction to increase the rate of collection of interstitial fluid.
  37. 37. The method of claim 35 further comprising applying ultrasonic vibrations to the skin or mucosa to increase the rate of collection of the selected analyte.
  38. 38. The method of claim 37 wherein said ultrasonic vibrations are modulated in frequency, intensity, phase, or a combination thereof.
  39. 39. The method of claim 38 wherein said ultrasonic vibrations are in the range of about 2000 Hz to about 100 MHz.
  40. 40. The method of claim 35 wherein movement of interstitial fluid by capillary action is enhanced by applying ultrasonic vibrations.
  41. 41. The method of claim 35 wherein said selected analyte is glucose.
  42. 42. The method of claim 35 further comprising applying an anticoagulant to inhibit obstruction of the holes or channels.
  43. 43. A method of transdermally or transmucosally delivering a drug in liquid form to a body comprising:
    (a) providing a device comprising:
    a base having a lower side and an upper side;
    a plurality of puncturing members extending from the lower side of the base, said puncturing members configured for puncturing said skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
    a plurality of holes extending from the lower side of the base to the upper side of the base, said holes configured for permitting a liquid to move therethrough by capillary action; and
    a network of channels configured in the upper side of said base to interconnect said holes, said network of channels including a reservoir;
    (b) contacting said device with the skin or mucosa such that said plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof;
    (c) supplying the drug to said reservoir such that said drug moves from the reservoir, through the channels and holes to the site of the punctures of the skin or mucosa and thus into the body.
  44. 44. The method of claim 43 further comprising applying pressure to increase the rate of delivery of the drug to the body.
  45. 45. The method of claim 43 further comprising applying ultrasonic vibrations to the skin or mucosa to increase the rate of delivery of the drug to the body.
  46. 46. The method of claim 45 wherein said ultrasonic vibrations are modulated in frequency, intensity, phase, or a combination thereof.
  47. 47. The method of claim 45 wherein said ultrasonic vibrations are in the range of about 2000 Hz to about 100 MHz.
  48. 48. The method of claim 43 wherein said drug in liquid form further comprises an anti-irritant, antiseptic, or analgesic to reduce trauma to the body due to the application of the device.
US09852935 1996-07-03 2001-05-10 Multiple mechanical microporation of skin or mucosa Abandoned US20020010412A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US2121296 true 1996-07-03 1996-07-03
US09202207 US6183434B1 (en) 1996-07-03 1997-07-03 Multiple mechanical microporation of skin or mucosa
US61416400 true 2000-07-11 2000-07-11
US09852935 US20020010412A1 (en) 1996-07-03 2001-05-10 Multiple mechanical microporation of skin or mucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09852935 US20020010412A1 (en) 1996-07-03 2001-05-10 Multiple mechanical microporation of skin or mucosa

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US61416400 Continuation 2000-07-11 2000-07-11

Publications (1)

Publication Number Publication Date
US20020010412A1 true true US20020010412A1 (en) 2002-01-24

Family

ID=21802981

Family Applications (2)

Application Number Title Priority Date Filing Date
US09202207 Expired - Lifetime US6183434B1 (en) 1996-07-03 1997-07-03 Multiple mechanical microporation of skin or mucosa
US09852935 Abandoned US20020010412A1 (en) 1996-07-03 2001-05-10 Multiple mechanical microporation of skin or mucosa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09202207 Expired - Lifetime US6183434B1 (en) 1996-07-03 1997-07-03 Multiple mechanical microporation of skin or mucosa

Country Status (8)

Country Link
US (2) US6183434B1 (en)
EP (1) EP0921840B1 (en)
JP (1) JP3942640B2 (en)
CA (1) CA2259437C (en)
DE (2) DE69722414D1 (en)
DK (1) DK0921840T3 (en)
ES (1) ES2200187T3 (en)
WO (1) WO1998000193A1 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040064087A1 (en) * 2002-08-29 2004-04-01 Lastovich Alexander G. Microabrader with controlled abrasion features
US20050119605A1 (en) * 2002-04-19 2005-06-02 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
US20080234626A1 (en) * 2006-04-26 2008-09-25 Chelak Todd M Multi-stage microporation device
US20080274166A1 (en) * 2005-06-10 2008-11-06 Transpharma Medical Ltd. Patch for Transdermal Drug Delivery
US20090053673A1 (en) * 2007-08-23 2009-02-26 Zimmer, Inc. Method for localized treatment of periodontal tissue
US20090118672A1 (en) * 2002-10-07 2009-05-07 Gonnelli Robert R Microneedle array patch
US20090187167A1 (en) * 2007-12-17 2009-07-23 New World Pharmaceuticals, Llc Integrated intra-dermal delivery, diagnostic and communication system
US20100229636A1 (en) * 2007-10-17 2010-09-16 Galit Levin Dissolution rate verification
US20100286588A1 (en) * 2007-10-09 2010-11-11 Transpharma Ltd. Magnetic patch coupling
US20100293807A1 (en) * 2007-10-29 2010-11-25 Transpharma Medical, Ltd. Vertical patch drying
EP2280645A2 (en) * 2008-05-02 2011-02-09 Aspect Medical Systems, Inc. Skin preparation device and biopotential sensor
US20110172486A1 (en) * 2008-06-27 2011-07-14 Quentin Andrew Pankhurst Magnetic microbubbles, methods of preparing them and their uses
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
WO2011109406A1 (en) * 2010-03-01 2011-09-09 Inovio Pharmaceuticals, Inc. A tolerable and minimally invasive skin electroporation device
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
CN103687644A (en) * 2011-06-28 2014-03-26 艾诺奥医药品有限公司 A miniminally invasive dermal electroporation device
CN104508675A (en) * 2012-05-30 2015-04-08 斯科特·麦克纳尔蒂 System, method and apparatus for electromagnetic detection and analysis of biometric information
US9011419B2 (en) 2007-12-05 2015-04-21 Syneron Medical Ltd Disposable electromagnetic energy applicator
US9238102B2 (en) 2009-09-10 2016-01-19 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
US9504826B2 (en) 2009-02-18 2016-11-29 Syneron Medical Ltd Skin treatment apparatus for personal use and method for using same
WO2018080923A1 (en) * 2016-10-28 2018-05-03 Georgetown University Non-invasive passive interstitial fluid collector
US9995295B2 (en) 2007-12-03 2018-06-12 Medipacs, Inc. Fluid metering device
US10000605B2 (en) 2012-03-14 2018-06-19 Medipacs, Inc. Smart polymer materials with excess reactive molecules

Families Citing this family (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100151406A1 (en) 2004-01-08 2010-06-17 Dmitri Boutoussov Fluid conditioning system
US20090143775A1 (en) * 1995-08-31 2009-06-04 Rizoiu Ioana M Medical laser having controlled-temperature and sterilized fluid output
US20060240381A1 (en) 1995-08-31 2006-10-26 Biolase Technology, Inc. Fluid conditioning system
US7828749B2 (en) 1996-05-17 2010-11-09 Roche Diagnostics Operations, Inc. Blood and interstitial fluid sampling device
US20020010406A1 (en) 1996-05-17 2002-01-24 Douglas Joel S. Methods and apparatus for expressing body fluid from an incision
EP1579814A3 (en) 1996-05-17 2006-06-14 Roche Diagnostics Operations, Inc. Methods and apparatus for sampling and analyzing body fluid
US7235056B2 (en) * 1996-05-17 2007-06-26 Amira Medical Body fluid sampling device and methods of use
DE69719761D1 (en) 1996-06-18 2003-04-17 Alza Corp Apparatus for improving transdermal administration of medicaments or the acceptance of body fluids
ES2289192T3 (en) * 1996-12-31 2008-02-01 Altea Therapeutics Corporation Microporation of tissue for delivery of bioactive agents.
WO1998011937A1 (en) * 1996-09-17 1998-03-26 Deka Products Limited Partnership System for delivery of drugs by transport
US6797276B1 (en) * 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US20040258703A1 (en) * 1997-11-14 2004-12-23 The Government Of The Us, As Represented By The Secretary Of The Army Skin-active adjuvants for transcutaneous immunization
US7135033B2 (en) 2002-05-23 2006-11-14 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants and topical substances
US20060149343A1 (en) * 1996-12-02 2006-07-06 Palomar Medical Technologies, Inc. Cooling system for a photocosmetic device
US6508813B1 (en) 1996-12-02 2003-01-21 Palomar Medical Technologies, Inc. System for electromagnetic radiation dermatology and head for use therewith
US8182473B2 (en) * 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US6527716B1 (en) 1997-12-30 2003-03-04 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
JP4056091B2 (en) 1997-05-15 2008-03-05 ザ ジェネラル ホスピタル コーポレーション Dermatology treatment method and apparatus
US6517532B1 (en) * 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
US6706000B2 (en) * 1997-11-21 2004-03-16 Amira Medical Methods and apparatus for expressing body fluid from an incision
US20030078499A1 (en) * 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
DE19800416C2 (en) * 1998-01-08 2002-09-19 Storz Karl Gmbh & Co Kg A device for treatment of body tissue, in particular near the surface soft tissue by means of ultrasound
US6173202B1 (en) 1998-03-06 2001-01-09 Spectrx, Inc. Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
EP1189281B1 (en) * 1998-06-30 2007-08-22 Micronas GmbH Chip-arrangement
US7384396B2 (en) 1998-07-21 2008-06-10 Spectrx Inc. System and method for continuous analyte monitoring
US7037277B1 (en) 1998-07-21 2006-05-02 Spectrx, Inc. System and method for fluid management in a continuous fluid collection and sensor device
EP1112021A1 (en) 1998-09-10 2001-07-04 Spectrx, Inc. Attribute compensation for analyte detection and/or continuous monitoring
US6708060B1 (en) * 1998-11-09 2004-03-16 Transpharma Ltd. Handheld apparatus and method for transdermal drug delivery and analyte extraction
US6597946B2 (en) * 1998-11-09 2003-07-22 Transpharma Ltd. Electronic card for transdermal drug delivery and analyte extraction
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
US6611706B2 (en) 1998-11-09 2003-08-26 Transpharma Ltd. Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
EP1189660B1 (en) * 1999-06-08 2006-05-03 Altea Therapeutics Corporation Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6256533B1 (en) * 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
EP1185202B1 (en) 1999-06-11 2006-11-29 SPECTRX, Inc. Alignment devices for fluid extraction from tissue and substance delivery
US6925317B1 (en) 1999-06-11 2005-08-02 Spectrx, Inc. Integrated alignment devices, system, and methods for efficient fluid extraction, substance delivery and other applications
JP2003502091A (en) * 1999-06-18 2003-01-21 ユニバーシティ オブ バージニア パテント ファウンデーション Fluid delivery device and related methods
US6623457B1 (en) 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US6835184B1 (en) 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
WO2001041863A1 (en) 1999-12-10 2001-06-14 Alza Corporation Device and method for enhancing microprotrusion skin piercing
US20020091377A1 (en) * 2000-01-25 2002-07-11 Anderson R. Rox Method and apparatus for medical treatment utilizing long duration electromagnetic radiation
EP1276426A4 (en) * 2000-03-09 2008-03-19 Nanopass Ltd Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
US6595947B1 (en) 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US8116860B2 (en) * 2002-03-11 2012-02-14 Altea Therapeutics Corporation Transdermal porator and patch system and method for using same
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
US6540675B2 (en) * 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6440096B1 (en) * 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
CN1471413A (en) 2000-09-08 2004-01-28 茵斯莱特有限公司 Devices, systems and methods for patient infusion
JP2002085561A (en) * 2000-09-14 2002-03-26 Terumo Corp Liquid injection needle
WO2002030506A3 (en) * 2000-10-12 2002-08-15 Ink Jet Tech Ltd Transdermal method
US7131960B2 (en) 2000-10-13 2006-11-07 Alza Corporation Apparatus and method for piercing skin with microprotrusions
US6882884B1 (en) 2000-10-13 2005-04-19 Soundskin, L.L.C. Process for the stimulation of production of extracellular dermal proteins in human tissue
US7419481B2 (en) 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
WO2003024518A3 (en) * 2001-09-14 2003-09-25 Procter & Gamble Microstructures for delivering a composition cutaneously to skin using rotatable structures
US7131987B2 (en) 2000-10-16 2006-11-07 Corium International, Inc. Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation
US6821281B2 (en) 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
WO2002064193A3 (en) 2000-12-14 2003-01-16 Georgia Tech Res Inst Microneedle devices and production thereof
US7027478B2 (en) 2000-12-21 2006-04-11 Biovalve Technologies, Inc. Microneedle array systems
US20080183162A1 (en) * 2000-12-28 2008-07-31 Palomar Medical Technologies, Inc. Methods And Devices For Fractional Ablation Of Tissue
US6888319B2 (en) * 2001-03-01 2005-05-03 Palomar Medical Technologies, Inc. Flashlamp drive circuit
CA2439882A1 (en) * 2001-03-02 2002-09-12 Palomar Medical Technologies, Inc. Apparatus and method for photocosmetic and photodermatological treatment
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
WO2002074173A1 (en) 2001-03-16 2002-09-26 Alza Corporation Method and apparatus for coating skin piercing microprojections
EP1752189A3 (en) 2001-04-20 2007-02-21 Alza Corporation Microprojection array having a beneficial agent containing coating
US6591124B2 (en) 2001-05-11 2003-07-08 The Procter & Gamble Company Portable interstitial fluid monitoring system
DE60213976T2 (en) * 2001-06-08 2007-04-26 Becton Dickinson And Co. needles device for manipulating or polishing array
US20020188223A1 (en) 2001-06-08 2002-12-12 Edward Perez Devices and methods for the expression of bodily fluids from an incision
US6501976B1 (en) 2001-06-12 2002-12-31 Lifescan, Inc. Percutaneous biological fluid sampling and analyte measurement devices and methods
US6721586B2 (en) 2001-06-12 2004-04-13 Lifescan, Inc. Percutaneous biological fluid sampling and analyte measurement devices and methods
US6793632B2 (en) 2001-06-12 2004-09-21 Lifescan, Inc. Percutaneous biological fluid constituent sampling and measurement devices and methods
US6875613B2 (en) 2001-06-12 2005-04-05 Lifescan, Inc. Biological fluid constituent sampling and measurement devices and methods
US6837988B2 (en) 2001-06-12 2005-01-04 Lifescan, Inc. Biological fluid sampling and analyte measurement devices and methods
US6790179B2 (en) 2001-08-01 2004-09-14 Johnson & Johnson Consumer Companies, Inc. Method of examining and diagnosing skin health
US6855117B2 (en) 2001-08-01 2005-02-15 Johnson & Johnson Consumer Companies, Inc. Method of treating the skin of a subject
US6840910B2 (en) 2001-08-01 2005-01-11 Johnson & Johnson Consumer Companies, Inc. Method of distributing skin care products
US20030028125A1 (en) * 2001-08-06 2003-02-06 Yuzhakov Vadim V. Physiological sample collection devices and methods of using the same
US6881203B2 (en) * 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
EP1471953B1 (en) 2001-09-21 2011-02-16 Valeritas, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
CA2464994A1 (en) * 2001-10-29 2003-06-26 Becton, Dickinson And Company Method and device for the delivery of a substance
US20040120964A1 (en) * 2001-10-29 2004-06-24 Mikszta John A. Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
US20040147984A1 (en) * 2001-11-29 2004-07-29 Palomar Medical Technologies, Inc. Methods and apparatus for delivering low power optical treatments
US6952604B2 (en) * 2001-12-21 2005-10-04 Becton, Dickinson And Company Minimally-invasive system and method for monitoring analyte levels
WO2003057059A1 (en) * 2001-12-27 2003-07-17 Palomar Medical Technologies, Inc. Method and apparatus for improved vascular related treatment
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
US6908453B2 (en) 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US6808506B2 (en) * 2002-02-04 2004-10-26 Becton, Dickinson And Company Device and method for delivering or withdrawing a substance through the skin
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US7060192B2 (en) 2002-05-09 2006-06-13 Lifescan, Inc. Methods of fabricating physiological sample collection devices
US7828827B2 (en) 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US7351252B2 (en) * 2002-06-19 2008-04-01 Palomar Medical Technologies, Inc. Method and apparatus for photothermal treatment of tissue at depth
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
JP2006511275A (en) * 2002-12-20 2006-04-06 パロマー・メディカル・テクノロジーズ・インコーポレイテッドPalomar Medical Technologies,Inc. Phototherapy device acne and other follicle disorders
US7578954B2 (en) * 2003-02-24 2009-08-25 Corium International, Inc. Method for manufacturing microstructures having multiple microelements with through-holes
US7052652B2 (en) 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US20080149524A1 (en) * 2003-03-27 2008-06-26 Rademaker William B Food containers including dental cleaning devices and other personal care items
US7530968B2 (en) 2003-04-23 2009-05-12 Valeritas, Inc. Hydraulically actuated pump for long duration medicament administration
JP2004343275A (en) * 2003-05-14 2004-12-02 Murata Mach Ltd Image processing system and scanner
US20050106226A1 (en) 2003-10-24 2005-05-19 Cormier Michel J. Pretreatment method and system for enhancing transdermal drug delivery
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
CA2543154A1 (en) 2003-10-28 2005-05-19 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
CA2543641A1 (en) 2003-10-31 2005-05-19 Alza Corporation Self-actuating applicator for microprojection array
WO2005051476A1 (en) * 2003-11-28 2005-06-09 Acrux Dds Pty Ltd Method and system for rapid transdermal administration
US7309335B2 (en) * 2003-12-31 2007-12-18 Palomar Medical Technologies, Inc. Dermatological treatment with visualization
CN1946452A (en) * 2004-01-09 2007-04-11 阿尔扎公司 Frequency assisted transdermal agent delivery method and system
US7819822B2 (en) * 2004-03-06 2010-10-26 Roche Diagnostics Operations, Inc. Body fluid sampling device
CA2560840C (en) * 2004-03-24 2014-05-06 Corium International, Inc. Transdermal delivery device
ES2611284T3 (en) 2004-04-01 2017-05-08 The General Hospital Corporation Apparatus for skin treatment and tissue remodeling
US20060020309A1 (en) * 2004-04-09 2006-01-26 Palomar Medical Technologies, Inc. Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US7315758B2 (en) 2004-06-03 2008-01-01 Lynntech, Inc. Transdermal delivery of therapeutic agent
US9089636B2 (en) * 2004-07-02 2015-07-28 Valeritas, Inc. Methods and devices for delivering GLP-1 and uses thereof
WO2006047290A3 (en) * 2004-10-21 2006-09-21 Bayer Healthcare Llc Method of determining the concentration of an analyte in a body fluid and system therefor
US20060253176A1 (en) * 2005-02-18 2006-11-09 Palomar Medical Technologies, Inc. Dermatological treatment device with deflector optic
CA2610158C (en) * 2005-06-03 2011-04-05 Biolase Technology, Inc. Tissue treatment device and method
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
CA2610289A1 (en) * 2005-06-24 2007-01-04 Biolase Technology, Inc. Visual feedback implements for electromagnetic energy output devices
US8801631B2 (en) * 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
CA2624059A1 (en) 2005-09-30 2007-04-12 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US20070194717A1 (en) * 2006-02-17 2007-08-23 Palomar Medical Technologies, Inc. Lamp for use in a tissue treatment device
US20070239142A1 (en) * 2006-03-10 2007-10-11 Palomar Medical Technologies, Inc. Photocosmetic device
US20070219604A1 (en) * 2006-03-20 2007-09-20 Palomar Medical Technologies, Inc. Treatment of tissue with radiant energy
US20070255355A1 (en) * 2006-04-06 2007-11-01 Palomar Medical Technologies, Inc. Apparatus and method for skin treatment with compression and decompression
US7662177B2 (en) * 2006-04-12 2010-02-16 Bacoustics, Llc Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy
JP4265696B2 (en) 2006-07-04 2009-05-20 凸版印刷株式会社 Method of manufacturing a micro-needle
JP4396776B2 (en) * 2006-07-27 2010-01-13 凸版印刷株式会社 Method of manufacturing a micro-needle
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
EP2121111B1 (en) * 2007-01-22 2018-03-14 Corium International, Inc. Applicators for microneedle arrays
US20090225060A1 (en) * 2007-05-03 2009-09-10 Rizoiu Ioana M Wrist-mounted laser with animated, page-based graphical user-interface
US7695469B2 (en) * 2007-01-25 2010-04-13 Biolase Technology, Inc. Electromagnetic energy output system
US9101377B2 (en) * 2007-01-25 2015-08-11 Biolase, Inc. Electromagnetic energy output system
US7815630B2 (en) * 2007-01-25 2010-10-19 Biolase Technology, Inc. Target-close electromagnetic energy emitting device
US20080186591A1 (en) * 2007-02-01 2008-08-07 Palomar Medical Technologies, Inc. Dermatological device having a zoom lens system
CA2686093C (en) 2007-04-16 2018-05-08 Corium International, Inc. Solvent-cast microneedle arrays containing active
US8143034B2 (en) * 2007-08-21 2012-03-27 Polytechnic Institute Of New York University Method for preparing long-chain hydroxyacids, diacids and oligomers and polymers thereof
WO2009048607A1 (en) 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
JP5178132B2 (en) * 2007-10-11 2013-04-10 キヤノン株式会社 The image processing system and image processing method
EP2293719B1 (en) * 2008-05-30 2015-09-09 Intuity Medical, Inc. Body fluid sampling device -- sampling site interface
CA2726067A1 (en) 2008-06-06 2009-12-10 Intuity Medical, Inc. Detection meter and mode of operation
KR101013581B1 (en) * 2008-08-06 2011-02-14 라종주 Electric Skin Treatment Device
WO2010124255A3 (en) * 2009-04-24 2011-02-03 Corium International, Inc. Methods for manufacturing microprojection arrays
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
US20150025459A1 (en) * 2009-07-29 2015-01-22 Allergan, Inc. Multi-site injection system
US8882748B2 (en) * 2009-10-08 2014-11-11 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including chemical permeation enhancers
US9017310B2 (en) * 2009-10-08 2015-04-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including microneedles
US9014799B2 (en) * 2009-10-08 2015-04-21 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including electrically-actuated permeation enhancement
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US9687641B2 (en) 2010-05-04 2017-06-27 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
WO2013020103A1 (en) 2011-08-03 2013-02-07 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
EP2839552A4 (en) 2012-04-18 2015-12-30 Cynosure Inc Picosecond laser apparatus and methods for treating target tissues with same
KR101372403B1 (en) * 2012-06-21 2014-03-25 주식회사 파나시 Pressure sensing automatic scanning system
US9999720B2 (en) 2012-09-27 2018-06-19 Palo Alto Research Center Incorporated Drug reconstitution and delivery device and methods
US9005108B2 (en) 2012-09-27 2015-04-14 Palo Alto Research Center Incorporated Multiple reservoir drug delivery device and methods
JP6372353B2 (en) 2012-11-09 2018-08-15 凸版印刷株式会社 Needle-like structure and a manufacturing method thereof
US9744341B2 (en) 2013-01-15 2017-08-29 Palo Alto Research Center Incorporated Devices and methods for intraluminal retention and drug delivery
CA2903583A1 (en) 2013-03-15 2014-09-18 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US20150038897A1 (en) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Low-Profile Microneedle Patch Applicator
US9297083B2 (en) 2013-12-16 2016-03-29 Palo Alto Research Center Incorporated Electrolytic gas generating devices, actuators, and methods
US9801660B2 (en) 2014-07-31 2017-10-31 Palo Alto Research Center Incorporated Implantable fluid delivery devices, systems, and methods
WO2016072350A1 (en) * 2014-11-07 2016-05-12 凸版印刷株式会社 Needle assembly for transdermal administration and method for manufacturing same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US4340048A (en) * 1981-03-28 1982-07-20 Alza Corporation Self-driven hypodermic injector
US4522622A (en) 1982-12-23 1985-06-11 Alza Corporation Multiple fluid pulse dispenser
US4775361A (en) * 1986-04-10 1988-10-04 The General Hospital Corporation Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport
GB2221394B (en) * 1988-08-05 1992-03-04 Eilert Eilertsen An injection device
US5169389A (en) * 1989-06-16 1992-12-08 Science, Inc. Fluid delivery apparatus
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5115805A (en) * 1990-02-23 1992-05-26 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin
US5137817A (en) * 1990-10-05 1992-08-11 Amoco Corporation Apparatus and method for electroporation
US5279544A (en) * 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
US5312456A (en) * 1991-01-31 1994-05-17 Carnegie Mellon University Micromechanical barb and method for making the same
US5223219A (en) 1992-04-10 1993-06-29 Biotrack, Inc. Analytical cartridge and system for detecting analytes in liquid samples
US5421816A (en) 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
US5582184A (en) * 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5458140A (en) * 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5445611A (en) * 1993-12-08 1995-08-29 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal delivery with ultrasound and chemical enhancers
EP0796128B1 (en) 1994-12-09 1999-03-10 Novartis AG Transdermal system
ES2536459T3 (en) * 1995-08-29 2015-05-25 Nitto Denko Corporation Microporation of human skin for drug delivery and monitoring applications
US5801057A (en) 1996-03-22 1998-09-01 Smart; Wilson H. Microsampling device and method of construction
ES2289192T3 (en) * 1996-12-31 2008-02-01 Altea Therapeutics Corporation Microporation of tissue for delivery of bioactive agents.
JP2828064B2 (en) * 1996-09-20 1998-11-25 日本電気株式会社 Suction leachate collection method and apparatus
US6071251A (en) 1996-12-06 2000-06-06 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests
US6155992A (en) 1997-12-02 2000-12-05 Abbott Laboratories Method and apparatus for obtaining interstitial fluid for diagnostic tests
JP4368060B2 (en) 1998-02-17 2009-11-18 アボット・ラボラトリーズAbbott Laboratories Collection and monitoring device of interstitial fluid
US6022316A (en) * 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337493B2 (en) 2002-04-19 2012-12-25 Syneron Medical Ltd Handheld transdermal drug delivery and analyte extraction
US20050119605A1 (en) * 2002-04-19 2005-06-02 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
US20110178518A1 (en) * 2002-04-19 2011-07-21 Transpharma Medical, Ltd. Handheld transdermal drug delivery and analyte extraction
US20090270792A1 (en) * 2002-08-29 2009-10-29 Lastovich Alexander G Microprotrusion arrays and methods for using same to deliver substances into tissue
US7166086B2 (en) 2002-08-29 2007-01-23 Becton, Dickinson And Company Substance delivery via a rotating microabrading surface
US7316671B2 (en) 2002-08-29 2008-01-08 Becton, Dickinson And Company Microprotrusion arrays and methods for using same to deliver substances into tissue
US7422567B2 (en) 2002-08-29 2008-09-09 Becton, Dickinson And Company Microabrader with controlled abrasion features
US8075826B2 (en) 2002-08-29 2011-12-13 Becton, Dickinson And Company Microprotrusion arrays and methods for using same to deliver substances into tissue
US20040077994A1 (en) * 2002-08-29 2004-04-22 Lastovich Alexander G. Microprotrusion arrays and methods for using same to deliver substances into tissue
US20040064087A1 (en) * 2002-08-29 2004-04-01 Lastovich Alexander G. Microabrader with controlled abrasion features
US8162901B2 (en) 2002-10-07 2012-04-24 Valeritas, Inc. Microneedle array patch
US20090118672A1 (en) * 2002-10-07 2009-05-07 Gonnelli Robert R Microneedle array patch
US20080274166A1 (en) * 2005-06-10 2008-11-06 Transpharma Medical Ltd. Patch for Transdermal Drug Delivery
US20080234626A1 (en) * 2006-04-26 2008-09-25 Chelak Todd M Multi-stage microporation device
US20090053673A1 (en) * 2007-08-23 2009-02-26 Zimmer, Inc. Method for localized treatment of periodontal tissue
US20100286588A1 (en) * 2007-10-09 2010-11-11 Transpharma Ltd. Magnetic patch coupling
US9037229B2 (en) 2007-10-09 2015-05-19 Syneron Medical Ltd Magnetic patch coupling
US8281675B2 (en) 2007-10-17 2012-10-09 Syneron Medical Ltd Dissolution rate verification
US20100229636A1 (en) * 2007-10-17 2010-09-16 Galit Levin Dissolution rate verification
US20100293807A1 (en) * 2007-10-29 2010-11-25 Transpharma Medical, Ltd. Vertical patch drying
US9995295B2 (en) 2007-12-03 2018-06-12 Medipacs, Inc. Fluid metering device
US9011419B2 (en) 2007-12-05 2015-04-21 Syneron Medical Ltd Disposable electromagnetic energy applicator
US20090187167A1 (en) * 2007-12-17 2009-07-23 New World Pharmaceuticals, Llc Integrated intra-dermal delivery, diagnostic and communication system
US9022973B2 (en) 2007-12-17 2015-05-05 New World Pharmaceuticals, Llc Integrated intra-dermal delivery, diagnostic and communication system
EP2280645A4 (en) * 2008-05-02 2013-09-18 Aspect Medical Systems Inc Skin preparation device and biopotential sensor
EP2280645A2 (en) * 2008-05-02 2011-02-09 Aspect Medical Systems, Inc. Skin preparation device and biopotential sensor
US9427396B2 (en) 2008-06-27 2016-08-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
US20110172486A1 (en) * 2008-06-27 2011-07-14 Quentin Andrew Pankhurst Magnetic microbubbles, methods of preparing them and their uses
US9504826B2 (en) 2009-02-18 2016-11-29 Syneron Medical Ltd Skin treatment apparatus for personal use and method for using same
US9238102B2 (en) 2009-09-10 2016-01-19 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
WO2011109406A1 (en) * 2010-03-01 2011-09-09 Inovio Pharmaceuticals, Inc. A tolerable and minimally invasive skin electroporation device
CN102905755A (en) * 2010-03-01 2013-01-30 因诺维奥制药公司 A tolerable and minimally invasive skin electroporation device
US20130066296A1 (en) * 2010-03-01 2013-03-14 Kate Broderick Tolerable and minimally invasive skin electroporation device
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
CN103687644A (en) * 2011-06-28 2014-03-26 艾诺奥医药品有限公司 A miniminally invasive dermal electroporation device
US10000605B2 (en) 2012-03-14 2018-06-19 Medipacs, Inc. Smart polymer materials with excess reactive molecules
CN104508675A (en) * 2012-05-30 2015-04-08 斯科特·麦克纳尔蒂 System, method and apparatus for electromagnetic detection and analysis of biometric information
WO2018080923A1 (en) * 2016-10-28 2018-05-03 Georgetown University Non-invasive passive interstitial fluid collector

Also Published As

Publication number Publication date Type
EP0921840B1 (en) 2003-05-28 grant
US6183434B1 (en) 2001-02-06 grant
JP3942640B2 (en) 2007-07-11 grant
EP0921840A1 (en) 1999-06-16 application
JP2000513971A (en) 2000-10-24 application
DK921840T3 (en) grant
EP0921840A4 (en) 2000-04-12 application
DE69722414D1 (en) 2003-07-03 grant
ES2200187T3 (en) 2004-03-01 grant
CA2259437C (en) 2006-12-05 grant
DE69722414T2 (en) 2004-05-19 grant
CA2259437A1 (en) 1998-01-08 application
DK0921840T3 (en) 2003-09-22 grant
WO1998000193A1 (en) 1998-01-08 application

Similar Documents

Publication Publication Date Title
Prausnitz Microneedles for transdermal drug delivery
US6623457B1 (en) Method and apparatus for the transdermal administration of a substance
US6749792B2 (en) Micro-needles and methods of manufacture and use thereof
US5985164A (en) Method for forming a filter
US5770076A (en) Micromachined capsules having porous membranes and bulk supports
US5985328A (en) Micromachined porous membranes with bulk support
US20030135201A1 (en) Microneedle with membrane
US6230051B1 (en) Device for enhancing transdermal agent delivery or sampling
US6835184B1 (en) Method and device for abrading skin
US20030187394A1 (en) Method and device for intradermally delivering a substance
Sivamani et al. Microneedles and transdermal applications
US20030135167A1 (en) Microneedles, microneedle arrays, and systems and methods relating to same
US20130150822A1 (en) Method for increasing the permeability of an epithelial barrier
US20060058602A1 (en) Interstitial fluid analyzer
US20060051404A1 (en) Microstructure roller system
US20020138049A1 (en) Microneedle devices and methods of manufacture and use thereof
US6562014B2 (en) Device and method for enhancing transdermal flux of agents being sampled
US6743211B1 (en) Devices and methods for enhanced microneedle penetration of biological barriers
US20080114298A1 (en) Low-Profile Microneedle Array Applicator
US6620123B1 (en) Method and apparatus for producing homogenous cavitation to enhance transdermal transport
US5913833A (en) Method and apparatus for obtaining biological fluids
Polla et al. Microdevices in medicine
US20120277697A1 (en) Systems and methods for collecting fluid from a subject
US20080125743A1 (en) Tissue Conforming Microneedle Array and Patch For Transdermal Drug Delivery or Biological Fluid Collection
US6908453B2 (en) Microneedle devices and methods of manufacture

Legal Events

Date Code Title Description
AS Assignment

Owner name: ALTEA THERAPEUTICS CORPORATION, GEORGIA

Free format text: CHANGE OF NAME;ASSIGNOR:ALTEA DEVELOPMENT CORP.;REEL/FRAME:013295/0519

Effective date: 20021120

Owner name: ALTEA DEVELOPMENT CORP., GEORGIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALTEA TECHNOLOGIES, INC.;REEL/FRAME:013295/0426

Effective date: 20021107

AS Assignment

Owner name: ALTEA DEVELOPMENT CORP., GEORGIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALTEA TECHNOLOGIES, INC.;REEL/FRAME:013699/0145

Effective date: 20021107

AS Assignment

Owner name: ALTEA THERAPEUTICS CORPORATION, GEORGIA

Free format text: CHANGE OF NAME;ASSIGNOR:ALTEA DEVELOPMENT CORP.;REEL/FRAME:013699/0641

Effective date: 20021108

AS Assignment

Owner name: ALTEA DEVELOPMENT CORP., GEORGIA

Free format text: CHANGE OF NAME;ASSIGNOR:ALTEA TECHNOLOGIES, INC.;REEL/FRAME:013746/0511

Effective date: 20030108